Stay updated on Olaparib vs Chemotherapy in BRCA+ Metastatic Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Olaparib vs Chemotherapy in BRCA+ Metastatic Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Olaparib vs Chemotherapy in BRCA+ Metastatic Breast Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The clinical trial record for the OlympiAD study is available again, with details on olaparib versus chemotherapy for metastatic breast cancer and information about study results, participants, and individual data access.
    Difference
    100%
    Check dated 2026-11-07T11:44:51.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.2 to v3.8.0 while the page continued to show a 403 error.
    Difference
    0.2%
    Check dated 2026-10-31T12:16:40.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces a terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T12:05:39.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page footer now displays revision v3.7.2 instead of v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-17T13:14:48.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The footer now displays site revision v3.7.1 instead of v3.7.0; the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T12:59:50.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error page, showing the 403 text and site chrome where the study record content would normally appear. This indicates access restrictions rather than substantive changes to the page's content or structure.
    Difference
    0.5%
    Check dated 2026-09-26T18:39:36.000Z thumbnail image

Stay in the know with updates to Olaparib vs Chemotherapy in BRCA+ Metastatic Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Olaparib vs Chemotherapy in BRCA+ Metastatic Breast Cancer Clinical Trial page.